Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A6, pseudogene (ANKRD20A6P)

Target: ANKRD20A6P
Molecular classification: Other (Pseudogene)

Overview

ANKRD20A6P (Ankyrin repeat domain 20 family member A6, pseudogene) is a human pseudogene that contains sequence similarity to ankyrin repeat domain genes[1][3][7][9]. Pseudogenes often arise from gene duplication or mutation events that disrupt protein-coding ability, and thus ANKRD20A6P does not produce a functional protein[10]. While some pseudogenes play roles in gene regulation (e.g., acting as microRNA decoys or generating non-coding RNAs), no specific regulatory or disease-associated function is currently described for ANKRD20A6P itself[1][9][10].

Mechanism of action

None known for drugs (see above).

Biological functions

MicroRNA decoy activity (competing for regulatory RNAs)Generation of non-coding RNAs with potential gene regulatory rolesEpigenetic and post-transcriptional regulation of parental genes (reported for some pseudogenes, but not ANKRD20A6P specifically)

Disease associations

None specifically known for ANKRD20A6P. Pseudogenes overall have been implicated in regulation of diseases, especially cancer, through indirect modulation of parental gene functions or competitive endogenous RNA networks

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A6, pseudogene (ANKRD20A6P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A6, pseudogene (ANKRD20A6P).

Explore the full profile